About
Akero Therapeutics is a clinical-stage biotech company focused on developing innovative treatments for serious metabolic diseases like MASH. Their lead product candidate, EFX, is currently being tested in multiple Phase 2b and Phase 3 clinical trials for patients with cirrhosis or pre-cirrhotic conditions due to MASH. Headquartered in South San Francisco, Akero aims to address high unmet medical needs through cutting-edge research and development.
Open Positions
Director /Sr. Director - Clinical Development
United StatesRemoteFull TimeUSD 182K–318K
Other
Jan 27
Associate Director, Drug Product Development
RemoteFull TimeUSD 153K–218K
Information Technology Jobs
Mar 31
Principal Scientist, CMC Analytical Development
United StatesRemoteFull TimeUSD 153K–218K
Other
Mar 31
